0001628280-24-011485.txt : 20240315 0001628280-24-011485.hdr.sgml : 20240315 20240315163047 ACCESSION NUMBER: 0001628280-24-011485 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240314 FILED AS OF DATE: 20240315 DATE AS OF CHANGE: 20240315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Koenig Sheldon L. CENTRAL INDEX KEY: 0001766524 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35986 FILM NUMBER: 24755288 MAIL ADDRESS: STREET 1: C/O PORTOLA PHARMACEUTICALS, INC. STREET 2: 270 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Esperion Therapeutics, Inc. CENTRAL INDEX KEY: 0001434868 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3891 RANCHERO DRIVE, SUITE 150 CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: 734-887-3903 MAIL ADDRESS: STREET 1: 3891 RANCHERO DRIVE, SUITE 150 CITY: ANN ARBOR STATE: MI ZIP: 48108 FORMER COMPANY: FORMER CONFORMED NAME: HDL THERAPEUTICS INC DATE OF NAME CHANGE: 20080513 4 1 wk-form4_1710534636.xml FORM 4 X0508 4 2024-03-14 0 0001434868 Esperion Therapeutics, Inc. ESPR 0001766524 Koenig Sheldon L. C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 1 1 0 0 President and CEO 0 Common Stock 2024-03-14 4 A 0 454000 0 A 766816 D Stock Option (right to buy) 2.05 2024-03-14 4 A 0 642000 0 A 2034-03-14 Common Stock 642000 642000 D Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be on June 15, 2024. /s/ Sheldon L. Koenig 2024-03-15